Science

Recognition of AKI is often delayed in hospitalized patients and the outcome of patients with dialysis-requiring AKI has not changed in the past decades, showing the great need for innovative diagnostic tools.

Recent research has identified new molecules that are informative and help clinicians understand the etiology of the patient’s clinical symptoms, paving the way for personalized medicine in the field of sepsis.

PenKid, is a dynamic biomarker for the real-time assessment of kidney function. penKid is a blood-based alternative reflecting true GFR that is applicable in routine laboratory testing independent of inflammation and common comorbidities.

Bio-ADM is a dynamic biomarker for the real-time assessment of endothelial function. Loss of endothelial function is causing the formation of edema, shock, and subsequent organ failure in critically ill patients.